Appetite support GLP-1 pathways can help eligible patients reduce appetite and food noise
The difference likely relates to the specific conformational changes each agonist induces in the receptor, which determines which G-protein pathways are preferentially activated
Reviewing studies where people using the drug had been asked about their food cravings and preferences, researchers showed that there was an overall lower desire for dairy and starchy foods, and salty and spicy foods, and also that they wanted a lower number of foods, particularly high-fat, non-sweet foods
"It was the best decision and the best thing I did for my body in a very long time," Williams said.
It is worth noting that research comparing GLP-1RAs with six anti-diabetes drugs revealed that there is no significant difference in lowering the risk of HCC between GLP-1RAs and metformin or DDP-4i (Wang et al., 2024)